Zuellig Nutritional Group (ZGNI) Expands Its U.S. Based Processing Capabilities and Product Line

LONG BEACH, Calif., December 10, 2004 - Zuellig Group North America (ZGNA), the holding company for ZGNI’s North American investments, today announced the expansion of its North American manufacturing and processing presence through the acquisition of Premium Processing, now Premium Performance Ingredients (PPI), based in Long Island, New York.

“We have been looking for the opportunity to expand our value-added manufacturing capabilities and increase our presence on the East Coast. With the acquisition of this business we will be able to offer our customers improved service and novel products including drum-to-hopper solutions,” stated David Turner, chairman, ZGNA. “PPI has an excellent reputation for its ability to provide a wide range of value-added solutions to customers in the nutraceutical, pharmaceutical and food industries.”

This acquisition allows ZGNI to not only offer customers ingredients, but also value-added manufacturing and processing capabilities, creating one-stop shopping for the development and manufacturing of novel products.

“PPI shares the same quality philosophy, image and values as ZGNI,” added Turner. “Existing PPI customers will continue to enjoy the same excellent customer service while benefiting from access to increased purchasing power and sourcing capabilities.”

Additionally, ZGNI is looking to increase manufacturing and processing capabilities on the West Coast in the near future. The company is also enhancing its capabilities in China by adding additional steam sanitization capacity and herbal powder manufacturing.

Zuellig Group North America, headquartered in Long Beach, California, is the holding company for Zuellig Nutritional Group’s North American investments including Zuellig Botanicals, Inc. (dba BI Nutraceuticals), Zeta Pharmaceuticals and Premium Performance Ingredients. Zuellig Nutritional Group supplies premium nutritional and pharmaceutical ingredients to healthcare and food companies, and in Asia it develops and markets innovative dietary supplements.

# # #


Peter Hafermann David Turner
BI Nutraceuticals ZGNA
310.669.2158 310.669.2138
[email protected] [email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.